Congress: What Are You Waiting For? Pass the Metastatic Breast Cancer Access to Care Act now.

19

March 4, 2025

NBCC begins its collaboration with Translational Research In Oncology and Novartis on the NATALEE clinical trial of CDK4/6 inhibitors in early high-risk HR+/HER2- breast cancer.